s6y

GridAI Technologies Corp.

Ticker
GRDX
CIK
1604191
Industry
Electric & Other Services Combined
Formerly
Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.

Financials 56

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q/A Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Jun 30, 2026
  4. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2026
  5. 10-Q Quarterly Report for period ending Mar 31, 2026
  6. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2026
  7. 10-K Annual Report for period ending Dec 31, 2025
  8. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2025
  9. 10-Q Quarterly Report for period ending Sep 30, 2025
  10. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2025

All 56 financials filings

News 216

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K/A Current report filing
  10. 8-K Current report filing

All 216 news filings

Ownership 198

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 198 ownership filings

Prospectus 119

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-1/A General form of registration statement for all companies including face-amount certificate companies
  4. S-1/A General form of registration statement for all companies including face-amount certificate companies
  5. S-1/A General form of registration statement for all companies including face-amount certificate companies
  6. S-1/A General form of registration statement for all companies including face-amount certificate companies
  7. S-1 General form of registration statement for all companies including face-amount certificate companies
  8. RW Registration Withdrawal Request
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. S-1/A General form of registration statement for all companies including face-amount certificate companies

All 119 prospectus filings

Proxies 41

  1. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRER14A Preliminary revised proxy soliciting materials
  5. PRER14A Preliminary revised proxy soliciting materials
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. PRER14A Preliminary revised proxy soliciting materials
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 41 proxies filings

Other 140

  1. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  2. EFFECT Notice of Effectiveness
  3. D Exempt (Private) Offering
  4. SCHEDULE 13D
  5. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  6. D Exempt (Private) Offering
  7. D Exempt (Private) Offering
  8. SCHEDULE 13G/A
  9. SCHEDULE 13G
  10. SCHEDULE 13G

All 140 other filings